Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biolin Scientific develops and markets advanced analytical instruments for surface science, thin film analysis, interfacial phenomena studies, and related applications. Their technologies are widely used in academic research as well as industrial R&D across life sciences, materials science, pharmaceuticals, energy, food & beverage sectors. The company does not have a drug pipeline or clinical results. Their QSense QCM-D technology enables nanoscale tracking of interactions at surfaces/interfaces—important for biomolecular interaction studies including antiviral drug development. Attension tensiometers provide precise measurement of surface/interfacial tension relevant to formulation sciences. No clinical programs or results exist since the company does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biolin Scientific.